DocGo Inc.DCGOEarnings & Financial Report
DocGo Inc. is a U.S.-headquartered mobile healthcare and on-demand medical service provider. It offers a range of solutions including in-home urgent care, diagnostic testing, telehealth consultations, and corporate wellness programs, serving individual patients, health systems, enterprise clients, and public sector organizations across North America.
Revenue
$120.8M
Gross Profit
N/A
Operating Profit
$-7.5M
Net Profit
$-7.6M
Gross Margin
N/A
Operating Margin
-6.2%
Net Margin
-6.3%
YoY Growth
-39.4%
EPS
$-0.03
DocGo Inc. Q4 FY2024 Financial Summary
DocGo Inc. reported revenue of $120.8M (down 39.4% YoY) for Q4 FY2024, with a net profit of $-7.6M (down 195.7% YoY) (-6.3% margin).
Key Financial Metrics
| Total Revenue | $120.8M |
|---|---|
| Net Profit | $-7.6M |
| Gross Margin | N/A |
| Operating Margin | -6.2% |
| Report Period | Q4 FY2024 |
DocGo Inc. Annual Revenue by Year
DocGo Inc. annual revenue history includes year-by-year totals (for example, 2025 revenue was $322.2M).
| Year | Annual Revenue |
|---|---|
| 2025 | $322.2M |
| 2024 | $616.6M |
| 2023 | $624.3M |
| 2022 | $440.5M |
DocGo Inc. Quarterly Revenue & Net Profit History
DocGo Inc. results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q4 FY2025 | $74.9M | -38.0% | $-142.3M | -190.0% |
| Q3 FY2025 | $70.8M | -48.9% | $-27.8M | -39.2% |
| Q2 FY2025 | $80.4M | -51.2% | $-11.2M | -13.9% |
| Q1 FY2025 | $96.0M | -50.0% | $-9.4M | -9.8% |
| Q4 FY2024 | $120.8M | -39.4% | $-7.6M | -6.3% |
| Q3 FY2024 | $138.7M | -25.7% | $5.5M | 4.0% |
| Q2 FY2024 | $164.9M | +31.4% | $6.5M | 4.0% |
| Q1 FY2024 | $192.1M | +70.0% | $11.2M | 5.8% |
Income Statement
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $192.1M | $164.9M | $138.7M | $120.8M | $96.0M | $80.4M | $70.8M | $74.9M |
| YoY Growth | 70.0% | 31.4% | -25.7% | -39.4% | -50.0% | -51.2% | -48.9% | -38.0% |
Balance Sheet
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $490.7M | $488.2M | $493.9M | $455.6M | $430.8M | $408.3M | $353.8M | $217.1M |
| Liabilities | $175.6M | $170.2M | $169.0M | $140.4M | $128.9M | $120.5M | $93.1M | $91.2M |
| Equity | $311.3M | $315.2M | $325.2M | $320.9M | $309.3M | $297.3M | $270.5M | $144.0M |
Cash Flow
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $-10.6M | $36.9M | $31.1M | $12.7M | $9.7M | $33.6M | $1.7M | $-10.5M |